Literature DB >> 34736073

Effects of a multicomponent intervention to slow mild cognitive impairment progression: A randomized controlled trial.

Qiao-Hong Yang1, Xia Lyu2, Qing-Ran Lin3, Zi-Wen Wang1, Li Tang1, Yu Zhao1, Qi-Yuan Lyu4.   

Abstract

BACKGROUND: Mild cognitive impairment affects 36% of people aged ≥65 years in China, around 50% of whom will develop dementia within 3 years. Early intervention can slow disease progression and delay the onset of dementia; however, whether a multicomponent intervention can decelerate the progression of mild cognitive impairment remains unknown.
OBJECTIVE: To evaluate the effects of a multicomponent intervention to slow mild cognitive impairment progression in Chinese patients.
DESIGN: Randomized controlled trial. SETTING(S) AND PARTICIPANTS: This study was conducted in two large regional communities in Guangzhou, China. Patients aged ≥ 65 years diagnosed with mild cognitive impairment were included.
METHODS: A total of 112 eligible participants were assigned to receive either a 6-month multicomponent intervention or usual care from September 2019 until January 2021. Data were collected at the beginning of the study and at 1, 3, and 6 months thereafter. The primary outcomes were cognitive function, comprehensive physical capacity, depression, and quality of life. Analysis followed the intention-to-treat principle. A generalized estimating equation was used to determine intervention effects.
RESULTS: At baseline, clinical characteristics did not differ significantly between groups. Significant interaction effects between time and group were detected (p < 0.001), indicating that the scores of five outcomes (cognitive function, short physical performance battery, timed up and go test, quality of life, and depression) of intervention and control groups changed differently over time. Participants in the intervention group were found to have a significantly greater improvement in cognitive function, physical function, quality of life, and fewer depression symptoms compared with the control group at baseline and follow-up periods.
CONCLUSIONS: This study demonstrates the beneficial effects of a multicomponent intervention on cognitive function, physical function, depression symptoms, and quality of life in people with mild cognitive impairment in the East Asia region. The effectiveness and feasibility of this intervention program suggest that its application should be promoted in community settings to delay the progression of disease in people with mild cognitive impairment. Registration number:ChiCTR1900026042 Tweetable abstract: The multicomponent intervention improves cognitive/physical function, depression, and quality of life, slowing cognitive impairment progression.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Cognitive function; Dementia; Depression; Elderly; Mild cognitive impairment; Patients; Physical function

Mesh:

Year:  2021        PMID: 34736073     DOI: 10.1016/j.ijnurstu.2021.104110

Source DB:  PubMed          Journal:  Int J Nurs Stud        ISSN: 0020-7489            Impact factor:   5.837


  3 in total

1.  Investigation of the Effect of Radiotherapy Dose on Chewing and Swallowing Structures in Head and Neck Cancer Patients Treated with Concomitant Chemoradiotherapy.

Authors:  Aydan Baştuğ Dumbak; Fatma Esen Aydınlı; Gözde Yazıcı; Önal İncebay; Zehra Yıldız; Deniz Yüce; Nilda Süslü; Oğuz Kuşçu; Maviş Emel Kulak Kayıkcı
Journal:  Dysphagia       Date:  2022-01-25       Impact factor: 3.438

2.  Comparison of Montreal Cognitive Assessment in Korean Version for Predicting Mild Cognitive Assessment in 65-Year and Over Individuals.

Authors:  Chiang-Soon Song; Hye-Sun Lee; Byung-Yoon Chun
Journal:  Occup Ther Int       Date:  2022-04-19       Impact factor: 1.565

3.  Social determinants and lifestyle factors for brain health: implications for risk reduction of cognitive decline and dementia.

Authors:  Susanne Röhr; Alexander Pabst; Ronny Baber; Christoph Engel; Heide Glaesmer; Andreas Hinz; Matthias L Schroeter; A Veronica Witte; Samira Zeynalova; Arno Villringer; Markus Löffler; Steffi G Riedel-Heller
Journal:  Sci Rep       Date:  2022-07-28       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.